{
    "clinical_study": {
        "@rank": "117739", 
        "arm_group": [
            {
                "arm_group_label": "no gastric residual evaluation", 
                "arm_group_type": "Experimental", 
                "description": "Infants will not receive routine gastric residual evaluation prior to feeding"
            }, 
            {
                "arm_group_label": "gastric residual evaluation", 
                "arm_group_type": "No Intervention", 
                "description": "Infants will receive routine gastric residual evaluation"
            }
        ], 
        "brief_summary": {
            "textblock": "Omitting evaluation of gastric residual contents prior to feeding very premature infants\n      will increase the feeding intake at 2 weeks, and total caloric intake and growth by 3 weeks,\n      as well as decrease the time required for parenteral nutrition."
        }, 
        "brief_title": "Effects Of Not Measuring Gastric Residual Content On Feeding Tolerance In Premature Infants iNFANTS", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Premature Infant", 
        "detailed_description": {
            "textblock": "Infants were randomized into 2 groups.  Group 1 had no gastric residuals evaluated prior to\n      feeding. Group 2 had gastric residuals evaluated prior to feeding.  Nutritional outcomes\n      were compared between groups."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Gestational age less than 32 weeks,\n\n          -  Birth weight less than or equal to 1250 grams,\n\n          -  Initial feeding tolerated within 48 hours of life\n\n        Exclusion Criteria:\n\n          -  Congenital or chromosomal disorders,\n\n          -  Severe complications leading to death in the first week of life"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "3 Days", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "61", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01965769", 
            "org_study_id": "2011-216", 
            "secondary_id": "Gerber003"
        }, 
        "intervention": {
            "arm_group_label": "no gastric residual evaluation", 
            "description": "Infants will not receive routine gastric residual evaluation prior to feeding.", 
            "intervention_name": "No gastric residual evaluation", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Very low birth weight infants", 
            "premature", 
            "nutrition", 
            "gastric residual"
        ], 
        "lastchanged_date": "October 15, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Gainesville", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "32611"
                }, 
                "name": "UF & Shands Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects Of Not Measuring Gastric Residuals Prior To Enteral Bolus Feeding On Gastrointestinal Function And Feeding Tolerance In Very Low Birth Weight Infants", 
        "overall_official": {
            "affiliation": "University of Florida", 
            "last_name": "Josef Neu, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Amount of feeding intake at 2 weeks", 
            "safety_issue": "No", 
            "time_frame": "Baseline to 2 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01965769"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Days to 120 mL/kg/d of enteral feedings", 
                "safety_issue": "No", 
                "time_frame": "Baseline to approximately 21 days"
            }, 
            {
                "measure": "Days of parenteral nutrition", 
                "safety_issue": "No", 
                "time_frame": "Baseline to approximately 21 days"
            }, 
            {
                "measure": "Incidence of late onset sepsis", 
                "safety_issue": "No", 
                "time_frame": "Baseline to approximately 90 days"
            }, 
            {
                "description": "Direct bilirubin", 
                "measure": "Weekly or biweekly liver function tests", 
                "safety_issue": "No", 
                "time_frame": "Baseline to 42 days"
            }, 
            {
                "description": "Weight, length and head circumference", 
                "measure": "Growth indices", 
                "safety_issue": "No", 
                "time_frame": "Baseline to approximately 90 days"
            }, 
            {
                "measure": "Length of hospital stay", 
                "safety_issue": "No", 
                "time_frame": "Baseline to approximately 90 days"
            }, 
            {
                "measure": "Incidence of necrotizing enterocolitis", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline to approximately 90 days"
            }, 
            {
                "measure": "Days requiring a central venous line", 
                "safety_issue": "No", 
                "time_frame": "Baseline to approximately 21 days"
            }
        ], 
        "source": "University of Florida", 
        "sponsors": {
            "collaborator": {
                "agency": "The Gerber Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Florida", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}